PL2272507T3 - Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową - Google Patents

Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową

Info

Publication number
PL2272507T3
PL2272507T3 PL10012336T PL10012336T PL2272507T3 PL 2272507 T3 PL2272507 T3 PL 2272507T3 PL 10012336 T PL10012336 T PL 10012336T PL 10012336 T PL10012336 T PL 10012336T PL 2272507 T3 PL2272507 T3 PL 2272507T3
Authority
PL
Poland
Prior art keywords
opioid analgesic
transdermal formulation
aloe composition
aloe
composition
Prior art date
Application number
PL10012336T
Other languages
English (en)
Inventor
Elisabeth Meyer
Peter Altenschöpfer
Angelika Baumann
Sarah Mcleod
Original Assignee
Luye Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34202336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2272507(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Luye Pharma Ag filed Critical Luye Pharma Ag
Publication of PL2272507T3 publication Critical patent/PL2272507T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL10012336T 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową PL2272507T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10340428.7A DE10340428B4 (de) 2003-09-02 2003-09-02 Opioides Analgetikum enthaltende transdermale Formulierung
EP10012336A EP2272507B1 (en) 2003-09-02 2004-07-26 Transdermal formulation comprising an opioid analgesic and an aloe composition
EP04763497A EP1660055B1 (en) 2003-09-02 2004-07-26 Transdermal formulation comprising an opioid analgesic and an aloe composition

Publications (1)

Publication Number Publication Date
PL2272507T3 true PL2272507T3 (pl) 2013-03-29

Family

ID=34202336

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04763497T PL1660055T3 (pl) 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową
PL10012336T PL2272507T3 (pl) 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04763497T PL1660055T3 (pl) 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową

Country Status (10)

Country Link
US (1) US20070077284A1 (pl)
EP (2) EP2272507B1 (pl)
JP (2) JP5244313B2 (pl)
CA (1) CA2534338C (pl)
DE (1) DE10340428B4 (pl)
DK (2) DK2272507T3 (pl)
ES (2) ES2394313T3 (pl)
PL (2) PL1660055T3 (pl)
PT (2) PT1660055E (pl)
WO (1) WO2005020966A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
EP2162183B1 (de) * 2007-06-25 2019-06-26 AMW GmbH Elektrophoretisches transdermales applikationssystem
EP2366388A1 (de) 2010-03-17 2011-09-21 Ratiopharm GmbH Nicht-okklusives transdermales therapeutisches System zur Verabreichung von Buprenorphin
WO2015025767A1 (ja) * 2013-08-21 2015-02-26 久光製薬株式会社 貼付剤
DE102014013448A1 (de) 2014-09-16 2016-03-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales Therapeutisches System umfassend Buprenorphin
US9656441B2 (en) 2015-01-08 2017-05-23 Alfred E. Tiefenbacher ( Gmbh & Co. Kg) Transdermal patch
JP6879734B2 (ja) * 2016-12-27 2021-06-02 小林製薬株式会社 皮膚浸透促進剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336243A (en) 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4751087A (en) 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4615699A (en) 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
ATE218328T1 (de) * 1996-03-25 2002-06-15 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit geringer applikationsdicke und hoher flexibilität sowie herstellungsverfahren
US6171594B1 (en) * 1996-07-10 2001-01-09 Colorplast A//S Adhesive agent and use of such agent
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US6946144B1 (en) * 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
EP1102589B1 (en) * 1998-07-16 2006-11-02 Memorial Sloan-Kettering Institute For Cancer Research Topical compositions comprising an opioid analgesic and an nmda antagonist
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
CN1507448A (zh) * 2001-03-02 2004-06-23 ���ŷ� N-丁-3-烯基降丁丙诺啡及其作为止痛药的用途
ATE403420T1 (de) * 2002-03-06 2008-08-15 Hexal Ag Transdermalsystem mit fentanyl
PT1485051E (pt) * 2002-03-20 2008-07-09 Euro Celtique Sa Processo de administração da buprenorfina para o tratamento da depressão
AU2007252249A1 (en) * 2006-05-18 2007-11-29 Merck Frosst Canada Ltd. Phenanthrene derivatives as mPGES-1 inhibitors

Also Published As

Publication number Publication date
DK1660055T3 (da) 2012-12-17
JP5789563B2 (ja) 2015-10-07
EP1660055A1 (en) 2006-05-31
EP2272507B1 (en) 2012-10-10
JP5244313B2 (ja) 2013-07-24
DE10340428B4 (de) 2015-02-12
ES2394313T3 (es) 2013-01-30
ES2394311T3 (es) 2013-01-30
US20070077284A1 (en) 2007-04-05
DE10340428A1 (de) 2005-03-24
PT1660055E (pt) 2012-12-21
WO2005020966A1 (en) 2005-03-10
EP1660055B1 (en) 2012-10-24
PT2272507E (pt) 2013-01-14
DK2272507T3 (da) 2012-12-17
CA2534338A1 (en) 2005-03-10
JP2007504183A (ja) 2007-03-01
JP2012188447A (ja) 2012-10-04
PL1660055T3 (pl) 2013-03-29
EP2272507A1 (en) 2011-01-12
CA2534338C (en) 2012-12-04

Similar Documents

Publication Publication Date Title
EP1613254A4 (en) TRANSDERMAL ANALGESIC COMPOSITION AND METHODS OF MAKING AND USING THE SAME
IL173152A0 (en) Transdermal hormone delivery system: compositions and methods
HUP0303313D0 (en) Transdermal pharmaceutical compositions
SI1592686T1 (sl) Inhibitorji giraze in njihova uporaba
IL175260A0 (en) Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
AP2006003694A0 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
KR100984939B9 (ko) 발사르탄 및 ｎｅｐ 저해제를 포함하는 제약학적 조성물
IL183332A0 (en) Capsaicinoid gel formulation and uses thereof
GB0614886D0 (en) Pharmaceutical composition and method of the transdermal delivery of magnesium
IL157662A0 (en) N-but-3-enyl norbuprenorphine and its use as analgesic
AU2003232848A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
GB0404327D0 (en) Pharmaceutical composition and method of using same
EP1545461A4 (en) COMBINED ANALGESIC COMPOSITION WITH IMMEDIATE AND PROLONGED RELEASE
EP1684681A4 (en) TRANSDERMALE HIGH AND LOW MOLECULAR CONNECTIONS
PT2272507E (pt) Formulação transdérmica compreendendo um analgésico opióide e uma composição de aloé
AU2007225022A8 (en) Non-codeine opioid analgesic process and formulations
EP1407771A4 (en) SOPHORIDINE AND ITS USE AS ANALYZIC
EP1962589A4 (en) SYNERGISTIC COMBINATIONS OF NORKETAMINE AND OPIOID ANALGETICS
PL1749090T3 (pl) Sposób formułowania i kompozycja do terapii komórkowej
AU2003236365A1 (en) Medicinal composition comprising acat inhibitor and insuline resistance improving agent
GB0406014D0 (en) Pharmaceutical composition and use
AU2003246888A1 (en) Use of devazepide in combination with an opioid analgesic for potentiating the effect of the analgesic
GB0608399D0 (en) Pharmaceutical composition and method of using same
GB0622684D0 (en) Feed preparation device and method of use
GB0321723D0 (en) New analgesic compositions and their administration